MedPath

The Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center logo
🇺🇸United States
Ownership
Subsidiary
Established
1826-01-01
Employees
5K
Market Cap
-
Website
http://www.case.edu/cancer

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
First Posted Date
2004-08-12
Last Posted Date
2020-07-27
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
21
Registration Number
NCT00002933
Locations
🇺🇸

Veterans Affairs Medical Center - Cleveland, Cleveland, Ohio, United States

🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-07-29
Last Posted Date
2010-07-08
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
28
Registration Number
NCT00002604
Locations
🇺🇸

Veterans Affairs Medical Center - Cleveland, Cleveland, Ohio, United States

🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

Phase 1
Completed
Conditions
Leukemia
First Posted Date
2004-07-29
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
30
Registration Number
NCT00002588
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2
Withdrawn
Conditions
Lymphoma
First Posted Date
2004-07-26
Last Posted Date
2012-03-20
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT00003929
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Lung Cancer
First Posted Date
2004-07-12
Last Posted Date
2016-03-22
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
1
Registration Number
NCT00087048
Locations
🇺🇸

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States

🇺🇸

Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Phase 2
Completed
Conditions
Recurrent Melanoma
Stage IV Melanoma
Interventions
Biological: recombinant interferon beta
First Posted Date
2004-06-11
Last Posted Date
2015-10-02
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
21
Registration Number
NCT00085306
Locations
🇺🇸

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2004-06-09
Last Posted Date
2014-01-09
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
5
Registration Number
NCT00006378
Locations
🇺🇸

Morristown Memorial Hospital, Morristown, New Jersey, United States

🇺🇸

Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

University Hospitals of Cleveland, Cleveland, Ohio, United States

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2
Withdrawn
Conditions
Lung Cancer
First Posted Date
2004-06-09
Last Posted Date
2014-01-15
Lead Sponsor
Case Comprehensive Cancer Center
Registration Number
NCT00006374

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2004-05-26
Last Posted Date
2014-01-08
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
30
Registration Number
NCT00006877
Locations
🇺🇸

Ireland Cancer Center, Cleveland, Ohio, United States

Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2004-05-19
Last Posted Date
2010-06-10
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
19
Registration Number
NCT00003154
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath